StockData
Vaxcyte, Inc. logo

Vaxcyte, Inc. (PCVX) stock

PCVXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 7/30
$68.62+2.26 (+3.41%)

Close on Nov 11, 2026Market cap $10.21BP/E –Yield 0.00%

Vaxcyte statistics

69 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
Feb 23, 2027 (estimated, after the close)
Last ex-dividend date
No dividends
Fundamentals through
Sep 30, 2026
Share price as of
Nov 11, 2026

Valuation ratiosIndustry

Market Cap
$10.21B
$282.97M
Enterprise Value
$8.92B
$154.96M
PB Ratio
4.10
2.17
P/TBV Ratio
4.10
2.39

Share statisticsIndustry

Shares Change (YoY)
4.83%
10.9%
Shares Change (QoQ)
3.12%
0.51%
Float
148M
49M
Shares Held by Insiders
0.77%
11.6%
Shares Held by Institutions
112.5%
56.4%

Short sellingIndustry

Short Interest
15M
–
Short Interest Change
5.03%
-0.76%
Short % of Float
10.4%
9.06%
Short % of Shares Outstanding
10.3%
6.38%
Days to Cover
6.72
5.16

Stock price statisticsIndustry

52-Week High
$90.75
–
52-Week Low
$42.40
–
20-Day Moving Average
$63.37
–
50-Day Moving Average
$62.13
–
200-Day Moving Average
$57.58
–
Average True Range (14)
$3.46
–
Price Change (1 Week)
4.48%
-0.50%
Price Change (1 Month)
2.72%
-0.33%
Price Change (3 Months)
16.6%
-17.2%
Price Change (6 Months)
26.5%
-20.1%
Price Change (YTD)
48.7%
-20.1%
Price Change (1 Year)
59.9%
-19.3%
Price Change (3 Years)
42.5%
-23.4%
Price Change (5 Years)
159.4%
-76.4%
Average Volume (10 Days)
2M
–
Average Volume (20 Days)
2M
–
Average Volume (90 Days)
2M
–
Relative Volume
0.89
0.73
Relative Strength Index (14)
59.5
47.6
Volatility (1 Year)
56.1%
80.2%
Beta (5 Years)
1.16
1.07

Returns on capitalIndustry

Return on Equity (ROE)
-42.7%
-51.3%
Return on Assets (ROA)
-37.3%
-40.3%
Return on Invested Capital (ROIC)
-81.8%
-34.0%
Return on Capital Employed (ROCE)
-45.7%
-37.7%

Financial positionIndustry

Current Ratio
4.56
3.30
Quick Ratio
4.37
2.37

EfficiencyIndustry

Profits Per Employee
-$2.27M
-$680.86K
Employee Count
507
75
WACC
10.7%
10.1%

Income statement (TTM)Industry

Operating Income
-$1.23B
-$20.20M
Net Income
-$1.15B
-$21.57M
EBITDA
-$1.21B
-$16.36M
EPS (Diluted)
-$8.07
-$0.77

Balance sheetIndustry

Net Cash (Debt)
$1.29B
$16.31M
Net Cash Per Share
$8.68
$0.70
Equity (Book Value)
$2.49B
$53.12M
Book Value Per Share
$16.73
$1.49
Tangible Book Value
$2.49B
$26.11M
Working Capital
$1.05B
$77.59M

Cash flow (TTM)Industry

Operating Cash Flow
-$962.01M
-$12.07M
Capital Expenditures
-$12.42M
-$939.00K
Free Cash Flow
-$974.42M
-$18.37M
FCF Per Share
-$6.55
-$0.42

Dividends and yieldsIndustry

Earnings Yield
-11.2%
-19.8%
FCF Yield
-9.54%
-8.81%
Dividend Yield
0.00%
1.86%
Shareholder Yield
0.00%
0.00%
Dividend Per Share
$0.00
$0.83
Years of Dividend Growth
0
0

Taxes and interestIndustry

Income Tax
$0
$79.50K

Scores and fair valueIndustry

Altman Z-Score
9.89
0.28
Piotroski F-Score
2
4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.

PeriodPCVXS&P 500DifferencePCVX per yearS&P 500 per year
1 month-3.9%-2.4%−1.5 pts
3 months+15.9%-1.2%+17.0 pts
Year to date+48.7%+12.3%+36.4 pts
1 year+50.3%+12.4%+37.8 pts
3 years+42.5%+78.8%−36.3 pts+12.5%+21.4%
5 years+166.4%+75.2%+91.2 pts+21.6%+11.9%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

15M PCVX shares were sold short on Oct 30, 2026, up 5.0% from the previous report, or 10.40% of the shares available to trade. At recent volumes it would take 6.7 days to buy them back. Over the last 20 sessions, 72.3% of the volume reported to FINRA was short selling.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 202615,359,758+5.0%2,284,7386.7
Oct 15, 202614,623,649-15.4%5,053,9042.9
Sep 30, 202617,290,712+7.2%1,517,42211.4
Sep 15, 202616,132,520+7.4%1,236,80313.0
Aug 31, 202615,016,514+1.5%947,05215.9
Aug 14, 202614,796,265+2.3%933,36815.8
Jul 31, 202614,464,951+1.6%976,18214.8
Jul 15, 202614,231,919-18.5%1,150,36012.4
Jun 30, 202617,468,070+19.4%2,527,6306.9
Jun 15, 202614,629,103+1.1%1,363,05910.7
May 29, 202614,473,801+5.0%1,635,3198.8
May 15, 202613,789,778-2.5%1,778,9767.8

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?